We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Wyeth Hits Another Generics Maker Over Effexor XR

Law360 (January 9, 2009, 12:00 AM EST) -- In its latest move to protect three patents for Effexor XR, Wyeth has hit Torrent Pharmaceuticals Ltd. over Torrent's bid to produce a generic version of the popular antidepressant.

The complaint, filed Thursday in the U.S. District Court for the District of Delaware, accuses Torrent Pharmaceuticals, headquartered in India, and its Kalamazoo, Mich.-based subsidiary, Torrent Inc., of working together to file an abbreviated new drug application with the U.S. Food and Drug Administration in order to sell an extended-release form of venlafaxine hydrochloride.

Wyeth alleges that...
To view the full article, register now.